Therapeutic management of patients with COVID-19: a systematic review
Top Cited Papers
Open Access
- 18 April 2020
- journal article
- review article
- Published by Elsevier in Infection Prevention in Practice
- Vol. 2 (3), 100061
- https://doi.org/10.1016/j.infpip.2020.100061
Abstract
No abstract availableKeywords
All Related Versions
This publication has 44 references indexed in Scilit:
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoVNature Communications, 2020
- Corticosteroid therapy for sepsis: a clinical practice guidelineBMJ, 2018
- Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocolSpringerPlus, 2015
- Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell CultureAntimicrobial Agents and Chemotherapy, 2014
- The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysisThe Journal of Infectious Diseases, 2014
- Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus InfectionClinical Infectious Diseases, 2011
- Chloroquine is a potent inhibitor of SARS coronavirus infection and spreadVirology Journal, 2005
- Effectiveness of Oseltamivir in Preventing Influenza in Household ContactsA Randomized Controlled TrialJAMA, 2001